Stay updated on Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0, indicating a minor site update.
    Difference
    0.1%
    Check dated 2026-03-25T20:46:50.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing v3.4.2; this is a minor site maintenance update that does not affect study information.
    Difference
    0.1%
    Check dated 2026-03-11T14:12:37.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the site. Removed older notices including the funding-lapse notice and Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T09:24:44.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added a government funding notice at the top of the page and updated the site version to v3.4.1, replacing the previous v3.4.0 note. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:43:18.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Show glossary added, revision updated to v3.4.0, and labels updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with capitalization changes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:04:50.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on the page. There are no substantive changes to the study details, eligibility criteria, or outcomes visible in the screenshots.
    Difference
    0.1%
    Check dated 2026-01-14T01:54:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Bevacizumab in Brain Metastases Clinical Trial page.